Market Cap ₹7568 Cr.
Stock P/E 37.1
P/B 5.4
Current Price ₹150.4
Book Value ₹ 27.7
Face Value 10
52W High ₹198.9
Dividend Yield 0%
52W Low ₹ 114.4
Prism Johnson Ltd is an India-based building materials organisation. It's segments are Tile and Bath (HRJ), and Ready Mixed Concrete (RMC) and Cement. The Cement section has a cement manufacturing ability of 5.6-meganewton tons at Satna in Madhya Pradesh. The Company makes Portland Pozzolana Cement (PPC) below numerous manufacturers, along with Champion, Champion Plus, and Duratech, in addition to Ordinary Portland Cement (OPC). HRJ section gives an end-to-end solution in tiles, sanitaryware and bath fittings, engineered marble and quartz, and production chemicals. HRJ phase has ceramic merchandise, which might be offered underneath various manufacturers, which include Johnson, Johnson Marbonite, Johnson Porselano and Johnson Endura. RMC section is a ready-blended concrete manufacturers. The Company operates about 96 ready-mixed concrete plants in over 44 cities in the country.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1504 | 1637 | 1854 | 1811 | 1663 | 1774 | 2112 | 1942 | 1838 | 1728 |
Other Income | 11 | 11 | 13 | 6 | 6 | 13 | 10 | 14 | 8 | 2 |
Total Income | 1515 | 1647 | 1867 | 1817 | 1670 | 1787 | 2121 | 1957 | 1846 | 1731 |
Total Expenditure | 1354 | 1521 | 1716 | 1690 | 1631 | 1714 | 1965 | 1791 | 1745 | 1595 |
Operating Profit | 160 | 127 | 151 | 126 | 39 | 73 | 157 | 166 | 101 | 136 |
Interest | 49 | 45 | 43 | 42 | 44 | 49 | 50 | 48 | 44 | 49 |
Depreciation | 70 | 75 | 94 | 94 | 90 | 101 | 105 | 93 | 95 | 99 |
Exceptional Income / Expenses | -2 | 0 | 11 | 0 | -7 | 0 | 0 | 0 | 248 | 0 |
Profit Before Tax | 40 | 6 | 24 | -10 | -102 | -78 | 3 | 25 | 210 | -13 |
Provision for Tax | 12 | 9 | 8 | 9 | -17 | -14 | 2 | 7 | 30 | 3 |
Profit After Tax | 27 | -2 | 16 | -19 | -85 | -64 | 0 | 18 | 180 | -15 |
Adjustments | 11 | 12 | 13 | 28 | 18 | 11 | 6 | -0 | 3 | 12 |
Profit After Adjustments | 38 | 9 | 30 | 9 | -66 | -53 | 7 | 18 | 183 | -3 |
Adjusted Earnings Per Share | 0.8 | 0.2 | 0.6 | 0.2 | -1.3 | -1.1 | 0.1 | 0.4 | 3.6 | -0.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4821 | 5027 | 5654 | 5223 | 5012 | 5508 | 6194 | 5956 | 5587 | 6306 | 7361 | 7620 |
Other Income | 16 | 157 | 36 | 152 | 92 | 66 | 27 | 29 | 39 | 93 | 36 | 34 |
Total Income | 4836 | 5184 | 5690 | 5375 | 5104 | 5574 | 6221 | 5985 | 5627 | 6399 | 7396 | 7655 |
Total Expenditure | 4509 | 4842 | 5297 | 4878 | 4651 | 5059 | 5587 | 5411 | 4960 | 5829 | 6990 | 7096 |
Operating Profit | 327 | 342 | 393 | 498 | 453 | 514 | 634 | 574 | 667 | 571 | 406 | 560 |
Interest | 234 | 280 | 296 | 286 | 221 | 232 | 226 | 258 | 217 | 193 | 197 | 191 |
Depreciation | 180 | 200 | 165 | 184 | 192 | 184 | 200 | 251 | 293 | 310 | 390 | 392 |
Exceptional Income / Expenses | 2 | 9 | 60 | -4 | 0 | 0 | -11 | -10 | -5 | 9 | -7 | 248 |
Profit Before Tax | -85 | -129 | -7 | 24 | 42 | 101 | 201 | 62 | 157 | 84 | -178 | 225 |
Provision for Tax | -24 | -44 | -12 | -2 | 27 | 46 | 92 | 74 | 16 | 40 | -20 | 42 |
Profit After Tax | -61 | -85 | 5 | 25 | 14 | 55 | 110 | -12 | 140 | 44 | -158 | 183 |
Adjustments | -2 | -1 | -2 | -22 | -16 | -13 | 7 | 22 | 31 | 48 | 55 | 21 |
Profit After Adjustments | -62 | -86 | 3 | 3 | -2 | 43 | 116 | 10 | 171 | 92 | -103 | 205 |
Adjusted Earnings Per Share | -1.2 | -1.7 | 0.1 | 0.1 | -0 | 0.8 | 2.3 | 0.2 | 3.4 | 1.8 | -2.1 | 4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 7% | 6% | 4% |
Operating Profit CAGR | -29% | -11% | -5% | 2% |
PAT CAGR | -459% | 0% | NAN% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 28% | 5% | 12% | 12% |
ROE Average | -12% | 1% | 2% | 1% |
ROCE Average | 1% | 7% | 9% | 9% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1149 | 1059 | 1054 | 998 | 995 | 1038 | 1126 | 1079 | 1242 | 1323 | 1207 |
Minority's Interest | 53 | 55 | 57 | 249 | 269 | 273 | 266 | 245 | 282 | 273 | 256 |
Borrowings | 1248 | 1448 | 1639 | 1477 | 1190 | 1152 | 1175 | 1504 | 1430 | 1177 | 958 |
Other Non-Current Liabilities | 244 | 209 | 211 | 251 | 266 | 307 | 500 | 717 | 787 | 873 | 873 |
Total Current Liabilities | 1872 | 1838 | 1889 | 2041 | 2146 | 2369 | 2364 | 2619 | 2523 | 2841 | 3292 |
Total Liabilities | 4566 | 4609 | 4849 | 5016 | 4866 | 5138 | 5431 | 6165 | 6264 | 6487 | 6585 |
Fixed Assets | 2339 | 2474 | 2413 | 2472 | 2415 | 2602 | 2626 | 2821 | 2946 | 2970 | 2947 |
Other Non-Current Assets | 605 | 402 | 481 | 548 | 803 | 801 | 890 | 961 | 1034 | 1238 | 1333 |
Total Current Assets | 1622 | 1733 | 1955 | 1996 | 1647 | 1735 | 1912 | 2380 | 2281 | 2278 | 2303 |
Total Assets | 4566 | 4609 | 4849 | 5016 | 4866 | 5138 | 5431 | 6165 | 6264 | 6487 | 6585 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 65 | 53 | 45 | 60 | 84 | 63 | 63 | 62 | 137 | 346 | 257 |
Cash Flow from Operating Activities | 260 | 57 | 199 | 462 | 676 | 587 | 654 | 667 | 1281 | 573 | 592 |
Cash Flow from Investing Activities | -320 | 79 | -57 | -127 | -236 | -407 | -330 | -657 | -265 | -320 | -320 |
Cash Flow from Financing Activities | 48 | -145 | -108 | -328 | -461 | -180 | -325 | 65 | -806 | -342 | -267 |
Net Cash Inflow / Outflow | -12 | -9 | 33 | 7 | -21 | 0 | -1 | 75 | 209 | -89 | 5 |
Closing Cash & Cash Equivalent | 53 | 45 | 78 | 84 | 63 | 63 | 62 | 137 | 346 | 257 | 262 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -1.24 | -1.71 | 0.05 | 0.06 | -0.04 | 0.84 | 2.31 | 0.2 | 3.4 | 1.82 | -2.05 |
CEPS(Rs) | 2.37 | 2.29 | 3.37 | 4.16 | 4.09 | 4.76 | 6.15 | 4.74 | 8.6 | 7.02 | 4.62 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 1 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 22.82 | 21.04 | 20.95 | 19.83 | 19.77 | 20.62 | 22.37 | 21.44 | 24.67 | 26.28 | 23.97 |
Core EBITDA Margin(%) | 5.92 | 3.37 | 5.79 | 6 | 6.49 | 7.95 | 9.39 | 8.66 | 10.61 | 7.22 | 4.79 |
EBIT Margin(%) | 2.84 | 2.75 | 4.68 | 5.38 | 4.72 | 5.9 | 6.6 | 5.09 | 6.32 | 4.18 | 0.24 |
Pre Tax Margin(%) | -1.61 | -2.35 | -0.12 | 0.41 | 0.75 | 1.78 | 3.11 | 0.99 | 2.65 | 1.27 | -2.3 |
PAT Margin (%) | -1.15 | -1.55 | 0.08 | 0.44 | 0.26 | 0.97 | 1.7 | -0.19 | 2.37 | 0.66 | -2.04 |
Cash Profit Margin (%) | 2.27 | 2.1 | 2.75 | 3.64 | 3.7 | 4.24 | 4.79 | 3.79 | 7.32 | 5.34 | 3.01 |
ROA(%) | -1.41 | -1.85 | 0.1 | 0.51 | 0.29 | 1.1 | 2.07 | -0.21 | 2.26 | 0.69 | -2.41 |
ROE(%) | -5.13 | -7.7 | 0.46 | 2.46 | 1.43 | 5.41 | 10.13 | -1.08 | 12.1 | 3.43 | -12.47 |
ROCE(%) | 4.99 | 4.78 | 8.95 | 9.53 | 8.5 | 10.97 | 13.91 | 10.06 | 11.88 | 9.46 | 0.68 |
Receivable days | 27.93 | 33.49 | 32.92 | 37.79 | 40.59 | 41.86 | 39.25 | 41.67 | 41.52 | 34.6 | 31.13 |
Inventory Days | 38.26 | 38.59 | 38.1 | 43.04 | 39.59 | 38.14 | 37.44 | 42.08 | 40.8 | 38.21 | 36.66 |
Payable days | 128.15 | 136.13 | 121.38 | 137.11 | 139.28 | 124.39 | 134.29 | 142.7 | 166.04 | 183.52 | 186.37 |
PER(x) | 0 | 0 | 1934.74 | 1410.28 | 0 | 128.69 | 41.45 | 152.38 | 38.61 | 63.33 | 0 |
Price/Book(x) | 1.84 | 1.81 | 4.81 | 4.08 | 4.96 | 5.27 | 4.28 | 1.42 | 5.33 | 4.39 | 4.39 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.52 | 3.29 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.84 | 0.78 | 1.27 | 1.18 | 1.36 | 1.35 | 1.08 | 0.56 | 1.4 | 1.11 | 0.88 |
EV/Core EBITDA(x) | 12.33 | 11.44 | 18.26 | 12.37 | 15.07 | 14.49 | 10.52 | 5.85 | 11.69 | 12.26 | 15.87 |
Net Sales Growth(%) | 4.88 | 4.27 | 12.49 | -7.63 | -4.03 | 9.88 | 12.47 | -3.85 | -6.2 | 12.87 | 16.71 |
EBIT Growth(%) | -8.62 | 1.35 | 90.87 | 7.29 | -15.15 | 26.73 | 28.2 | -24.22 | 16.7 | -25.94 | -93.22 |
PAT Growth(%) | -259.17 | -40.43 | 105.67 | 424.07 | -43.59 | 285.96 | 99.27 | -111.36 | 1274.39 | -68.68 | -458.89 |
EPS Growth(%) | -238.82 | -37.98 | 103.04 | 10.17 | -162.37 | 2458.38 | 173.9 | -91.37 | 1605.11 | -46.41 | -212.49 |
Debt/Equity(x) | 1.76 | 1.99 | 2.12 | 2.22 | 1.99 | 1.98 | 1.7 | 2.08 | 1.39 | 1.18 | 1.22 |
Current Ratio(x) | 0.87 | 0.94 | 1.04 | 0.98 | 0.77 | 0.73 | 0.81 | 0.91 | 0.9 | 0.8 | 0.7 |
Quick Ratio(x) | 0.55 | 0.63 | 0.66 | 0.66 | 0.51 | 0.47 | 0.51 | 0.63 | 0.67 | 0.52 | 0.47 |
Interest Cover(x) | 0.64 | 0.54 | 0.98 | 1.08 | 1.19 | 1.43 | 1.89 | 1.24 | 1.72 | 1.44 | 0.1 |
Total Debt/Mcap(x) | 0.96 | 1.1 | 0.44 | 0.54 | 0.4 | 0.38 | 0.4 | 1.47 | 0.26 | 0.27 | 0.28 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 | 74.87 |
FII | 3.35 | 3.29 | 3.34 | 3.42 | 3.47 | 3.5 | 3.59 | 3.72 | 3.9 | 3.87 |
DII | 6.92 | 6.22 | 5.45 | 4.33 | 4.11 | 4.37 | 4.64 | 4.85 | 5.11 | 5.05 |
Public | 14.85 | 15.61 | 16.33 | 17.37 | 17.55 | 17.26 | 16.9 | 16.56 | 16.12 | 16.21 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 | 37.69 |
FII | 1.69 | 1.65 | 1.68 | 1.72 | 1.74 | 1.76 | 1.81 | 1.87 | 1.97 | 1.95 |
DII | 3.49 | 3.13 | 2.75 | 2.18 | 2.07 | 2.2 | 2.33 | 2.44 | 2.57 | 2.54 |
Public | 7.48 | 7.86 | 8.22 | 8.75 | 8.83 | 8.69 | 8.51 | 8.33 | 8.11 | 8.16 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 | 50.34 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About